MICROSPHERES FOR EMBOLIZATION WITH OR WITHOUT DOXORUBICIN ADMINISTRATION - Argentina Medical Device Registration
Access comprehensive regulatory information for MICROSPHERES FOR EMBOLIZATION WITH OR WITHOUT DOXORUBICIN ADMINISTRATION in the Argentina medical device market through Pure Global AI's free database. This Revalidation of Registration I-II-III-IV medical device is registered with Argentina's ANMAT (National Administration of Drugs, Food and Medical Technology). The device was registered on December 11, 2023.
This page provides complete registration details including product code (799-65), brand name (Biosphere Medical), authorized representative information, registration type, and regulatory compliance data from the official Argentina ANMAT medical device database. Pure Global AI offers free access to Argentina's medical device registry, helping global MedTech companies navigate Argentina regulations efficiently.
HepaSphereTM Microspheres for Embolization with or Without Doxorubicin or Irinotecan Administration V125HS 20-40 μm 25 mg V150HS 20-40 μm 50 mg V225HS 30-60 μm 25 mg V250HS 30-60 μm 50 mg V325HS 50-100 μm 25 mg V350HS 50-100 μm 50 mg V525HS 100-150 μm 25 mg V550HS 100-150 μm 50 mg V725HS 150-200 μm 25 mg V750HS 150-200 μm 50 mg
HepaSphereTM Microesferas para embolización con o sin administración de doxorubicina o irinotecan V125HS 20-40 µm 25 mg V150HS 20-40 µm 50 mg V225HS 30-60 µm 25 mg V250HS 30-60 µm 50 mg V325HS 50-100 µm 25 mg V350HS 50-100 µm 50 mg V525HS 100-150 µm 25 mg V550HS 100-150 µm 50 mg V725HS 150-200 µm 25 mg V750HS 150-200 µm 50 mg